OmniAb
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OmniAb and other ETFs, options, and stocks.About OABI
OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies.
CEOMatthew William Foehr
CEOMatthew William Foehr
Employees114
Employees114
HeadquartersEmeryville, California
HeadquartersEmeryville, California
Founded2015
Founded2015
Employees114
Employees114
OABI Key Statistics
Market cap276.39M
Market cap276.39M
Price-Earnings ratio-3.23
Price-Earnings ratio-3.23
Dividend yield—
Dividend yield—
Average volume310.74K
Average volume310.74K
High today$1.94
High today$1.94
Low today$1.90
Low today$1.90
Open price$1.91
Open price$1.91
Volume239.60K
Volume239.60K
52 Week high$4.02
52 Week high$4.02
52 Week low$1.22
52 Week low$1.22
Stock Snapshot
As of today, OmniAb(OABI) shares are valued at $1.93. The company's market cap stands at 276.39M, with a P/E ratio of -3.23.
During the trading session on 2026-01-09, OmniAb(OABI) shares reached a daily high of $1.94 and a low of $1.90. At a current price of $1.93, the stock is +1.6% higher than the low and still -0.5% under the high.
Trading volume for OmniAb(OABI) stock has reached 239.6K, versus its average volume of 310.74K.
Over the past 52 weeks, OmniAb(OABI) stock has traded between a high of $4.02 and a low of $1.22.
Over the past 52 weeks, OmniAb(OABI) stock has traded between a high of $4.02 and a low of $1.22.
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own OABI. This list is generated using Robinhood data, and it’s not a recommendation.